Trump Is Right About the Panama Canal
We're a Coalition That Has to Work Through Disagreements
You Don't Need to Get Past the Second Paragraph to Know This Politico...
CNN Reporter Has a Shocking Take on Joe Biden's Legacy
Fani Willis Gets Some More Bad News
Guess Who a Majority of Americans Blame for the UnitedHealthcare CEO Shooting
New Poll Reveals How Americans Feel About Political News Right Now
Brand New Photos Expose Joe Biden's Lies About Involvement With Hunter's Business Dealings
Celebrating Media Mayhem with the Heckler Awards - Part 4: The Individual Categories
New York's Radical Fight Against 'Climate Change' Continues
Morrison Hotel, Made Famous By the Doors, Burns Down After Squatters Refuse to...
Trump Asks Supreme Court to Delay TikTok Ban
Why Does Bill Gates Want to Visit Trump at Mar-a-Lago?
The New York Times Celebrates Faith Leaders Who Bless Abortion Clinics
Retiring Congresswoman Torches Older Democrats for Staying in Congress ‘Forever’
Tipsheet

Tom Marino out as 'Drug Czar'

Rep. Tom Marino (R-PA) has withdrawn his name from consideration to be America's "drug czar" to lead the Office of National Drug Control Policy after a Washington Post/"60 Minutes" report detailed how the representative supposedly encouraged legislation that would protect drug companies from DEA regulations. The president has accepted Marino's decision.

Advertisement

Trump was asked about the "60 Minutes" report Monday at the White House Rose Garden, to which he simply replied he'd be "looking into" it, while adding that Marino was "a great guy."

The president added that he would be declaring the opioid crisis a national emergency next week.

“This country and, frankly, the world has a drug problem,” he said. “We’re going to do something about it.”

Following the WaPo report, horrified legislators insisted they were "fooled" by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. The New York Times explained how it undermined drug policy.

Advertisement

The legislation that Mr. Marino championed undermined the Drug Enforcement Administration’s ability to freeze suspicious shipments of drugs — making it difficult to cut the flow of painkillers to the black market — and it was a top priority of the drug industry.

Sen. Claire McCaskill (D-MO) is introducing legislation to repeal the bill.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement